it's not about what it's worth... only what people think it's worth it is better to remain silent and be thought a fool... Jesse Livermore: ”Throughout all my years of investing I’ve found that the big money was never made in the buying or the selling. The big money was made in the waiting.” Peter Lynch once said, “Far more money has been lost by investors preparing for corrections, or trying to anticipate corrections, than has been lost in corrections themselves.” to be cont'd
BioGroup Team (BGT) is a self-organized panel of professionals with a shared interest in trading and investing in the healthcare and life sciences sectors. Our experts’ editorial team is comprised of individuals with extensive background in research, science, economics and trading in the biotechnology / health sectors.
Our main focus is identifying and analyzing cutting edge biotechnology companies that are under or over-valued. We obtain information from public sources that we believe to be accurate and reliable, and not from company insiders or persons who have a relationship with company insiders. Our aim is to deliver a succinct analysis which is clear and detailed enough to provide the reader with a better understanding of our findings and conclusions.
MagicDiligence provides useful, simple, and effective stock screening tools inspired by Joel Greenblatt's Magic Formula® Investing methodology. Our Spells give value and growth investors a list of great stock candidates every day, and our advanced Spell Caster lets you create the Magic-style stock screen you've always wanted! Learn more about our exclusive set of investing tools today!
Shark Traders is a prop firm providing online access and leverage for trading on NYSE, NASDAQ and AMEX to traders from all over the world. We work with few clearing firms and serve hundreds of traders helping their business grow.
61 year old Emeritus Civil Engineer (B.Sc and Ph.D.) with 21 years of practical experience. For the last 20 years (the first 5 years in tandem with engineering) my income is mainly due to stock and future trading based on standard technical analysis, the only reliable tool for achieving at least 60-70% successful trades.
The "cfe" identity name contains the 3 fundamental technical analysis tools, i.e. Candlesticks, Fibonacci Retracements and Elliot Waves.
I have been exposed to stocks since young as my father made fortunes from savvy and shrewd stock investing which have brought us much wealth and prosperity after starting off in extreme poverty.
I am a keen lifelong student of economic and stock market history, which I believe gives tremendous insights and understanding to the current market environment. I use economic and market fundamentals to guide my trading decisions, and then employ time tested technicals and indicators to more effectively time entry and exit points.
I have called and profited heavily from the 2014-2015 collapse in oil prices, the August 2015 correction and the big fall in small cap biotechs, and from emerging market companies who export to the US. I employ both long and short strategies to provide a practical and commonsense approach to profit from the market.
Besides stock investing, I have a stable job, and am a part-time entrepreneur.
Former broker, now an independent analyst/writer on Seeking Alpha and founder and editor of the Growth Stock Forum. Focusing on small-cap, mid-cap and biotech stocks. Looking for substantial sales and earnings growth potential and seeking the best risk-adjusted returns from my stock selection. Taking advantage of medium to long-term momentum.
My articles represent my personal opinion and analysis and should not be regarded as investment advice in any way. Readers and subscribers should do their own due diligence and/or consult their financial advisor before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.
Exclusive research: http://seekingalpha.com/author/oneil-trader/research
I am an individual and occasional investor with a passion for biotechnology and stocks. I am working as an engineer with ties to the healthcare sector.
I build investment theses based on thorough personal research and end up picking only stocks that I think hold a very high and long-term potential. I specialize in micro-cap and/or European biotechs, tracking undervalued opportunities and basing my investment choices on the deep analysis of a company's fundamentals and its long-term perspective (at least several years).
Follow me on twitter: https://twitter.com/Logribel
I am Chirag Shah. I have a Masters degree in Pharmacy. Pharma and Biotech are my passion. I am an opportunistic investor. Currently I am working with a growing generic drug development company as a pharmaceutical formulation scientist.
Brad Thomas is a research analyst and he currently writes weekly for Forbes and Seeking Alpha where he maintains research on many publicly-listed REITs. In addition, Thomas is the Senior Analyst at iREIT Forbes and Editor of the Forbes Real Estate Investor, a monthly subscription-based newsletter.
Thomas has also been featured in Forbes Magazine, Kiplinger’s, US News & World Report, Money, NPR, Institutional Investor, GlobeStreet, and Fox Business. He was the #1 contributing analyst on Seeking Alpha in 2014 (as ranked by TipRanks) and he is currently writing a book on the legendary investor Donald Trump.
Thomas has co-authored a book (The Intelligent REIT Investor) that is available on Amazon.
Thomas received a Bachelor of Science degree in Business/Economics from Presbyterian College where he played basketball. He resides in South Carolina with his wife and kids.
I work at the United States Patent and Trademark Office (USPTO). I am a patent attorney and my specialties include bio-medical devices, surgery, drug delivery, microbiology and nanotechnology. Prior to the USPTO, I worked in the IT and biotechnology industries.
My training as a patent attorney gives me the skills to analyze investment opportunities in new technologies and my job with the USPTO gives me access to the search tools and instruments of a patent examiner which I use to research stocks in my spare time and debunk questionable articles regarding new technologies posted by others.
I've been investing ever since I turned 18 (since 1998). My primary goal here on Seeking Alpha is to research investment opportunities, make money, have lively debates, and have fun.
Moon Kil Woong is currently a VP at a SME. Previously he was a tech stock consultant, VP of Research at ING, and sell side Director at Crédit Agricole Indosuez. Moon Kil Woong has a Masters in Public Administration from SJSU.
I am the annoying guy you meet at a cocktail party who knows a great deal about things, which at their core, are entirely uninteresting. My hobbies are tube amplifiers, non-linear financial modeling and squash.
I am mostly a value investor in individual stocks. Mostly in great North American companies. I reinvest dividends. I try to hold forever. Sometimes I invest in small to mid cap companies with solid cash flow, balance sheets, and compelling price ratios.
I will occasionally chase quality growth. Higher PEs, but with a justified growth rate. I however disdain companies that don't make a profit.
That said, yes, I use even smaller money to engage in deep risk. I'll play the greater fool theory. I'll ride speculative hype and hope to have a faster finger. Here I do my best to time the irrationality of the herd and the pump and dump collusion of smart money interests.
I dollar cost average into index funds. When I have no alternative, such as with 401k plans. But when possible, I convert to a self managed IRAs. I prefer to do it myself, avoiding fees and the inefficiencies of indices.
I keep an eye on important macroeconomic metrics. The S&P500 PE. The tmc:gnp ratio. Distributions of income & wealth. Employment. Any systemic risk.
Stocks: AA. AAPL. AWK. BAC. CBI. CNI. CSCO. DEO. DNOW. DOW. DVN. FB. GLW. IBB. IBM. INTC. JNJ. KO. MRO. MSFT. MT. NOV. RDS-B. V. WFC. XOM.
REITs: SBRA. STWD.
Funds: VWELX. VMMXX. FTAWX. T Rowe Price Blue Chip Growth Trust t2.
Annuity Funds: Deutsche Equity 500 Index VIP B.
I work in hi-tech. I am essentially a software engineer. I work in silicon valley & often enough on wall street. I am a former US Army officer, where ironically I was introduced to more formal investing.
I'm always seeking alpha. I'm open to collaborating in identifying good investing opportunities. I'm always learning and welcome criticism.
I was trained in finance, but work in strategy. I invest very infrequently, and balance my portfolio once a year. I buy and hold hold indices and volatility ETFs. I trade a little bit on the side, but that's pure gambling, for fun.
INDEPENDENT Financial Advisor / Professional Investor- with over 30 years of navigating the Stock market's "fear and greed" cycles that challenge the average investor. Investment strategies that combine Theory, Practice and Experience to produce Portfolios focused on achieving positive returns over a period of time. Providing advice in helping to avoid the pitfalls and traps that wreak havoc on your portfolio with a focus on Income and Capital Preservation.
I manage the capital of only a handful of families and I see it as my number one job to protect their financial security. They don’t pay me to sell them investment products, beat an index, abandon true investing for mindless diversification or follow the Wall Street lemmings down the primrose path. I manage their money exactly as I manage my own so I don’t take any risk at all unless I strongly believe it is worth taking.
Blogging here on SA is part of my research. I write to find out what I think.
I invite you to join the family of satisfied clients send an e-mail :email@example.com
Specialize in the investment in and trading of "deep-value" high-yield securities, including debt, preferred shares, common shares, put/call options, and ETF's, for my own and family accounts only. Have over seventeen years experience personally directing our personal and family accounts on a mostly full-time basis.
Was previously an international-business executive, general manager and entrepreneur in the medical-technology industry. Also provided consulting, related to general management, new-venture formation and acquisition of venture capital.
Education: Brown University, School of Engineering (Sc. B. '71); University of Virginia, Darden School of Business Administration (MBA '73).
Present Home: Sarasota, FL
Previous Homes: New York City, Mountain View, CA
Hometown: Baltimore, MD
I am a 15 year veteran of the buy-side, with over a decade of experience in Investment Management, at one time overseeing several billion dollars in hedge fund assets for institutional clients. Currently, I advise wealthy families on their investment portfolios as well as trade my own money.
Articles on Seeking Alpha are meant to be a snapshot of my views, but do not necessarily always reflect my portfolio. I also try to write on controversial and contrarian topics.
All money received from Seeking Alpha activities is currently being donated to various charities, including the World Food Program and UNICEF.
I started my career on Wall Street at GFI Group one of the largest inter-dealer brokers. I was most recently the Equity Strategist for an institutional boutique brokerage firm, Momentum Trading Partners, where I provided ideas and advice to hedge funds, prop desks and mutual funds.
Since 1998, WhisperNumber.com has been the leader in social media analytics ('crowd sourced estimates') for earnings. Receive email alerts on those companies most likely to move higher or lower when they beat or miss the whisper number. These are the Whisper Reactors. http://www.whispernumber.com/suboptions_wr.jsp When earnings season gets underway, traders, analysts and investors are watching closely to see if companies' results squared with Wall Street's expectations. Of particular interest is the "whisper number". A veteran in the business, WhisperNumber.com takes a unique approach: its earnings estimates come from regular polling of its members. The site points to independent academic studies supporting its claims that the crowd is wiser than the Wall Street priesthood (www.whispernumber.com/study.jsp). WhisperNumber.com's free registration buys voluminous information related to the profit histories of companies entering earnings season. Type a ticker into its search engine for an exhaustive earnings profile of a company, alongside a calendar of coming earnings and an education center with whisper strategies for trading. A subscription payment of $395 for six months buys access to the company's premium offering, Whisper Reactors (http://www.whispernumber.com/signIn_wr.jsp), a list of highly volatile companies whose prices show a high correlation to their earnings outcomes. WhisperNumber.com claims a variety of double-digit returns for different types of plays over holding periods of 1-to-30 days. Trading on whispers is a technical play on market psychology, rather than a bet on a company's fundamental strengths. To a technician, share price is just a market-clearing mechanism that strikes a balance between buyer greed and seller fear.
Sam Antar is a convicted felon and a former CPA. As the CFO of Crazy Eddie, Mr. Antar helped mastermind one of the largest securities frauds uncovered during the 1980s.
Today, Sam Antar is a forensic accountant. His primary work focuses on identifying and investigating public companies engaged in securities fraud by examining their accounting practices and performing an in-depth (deep-dive) financial analysis. His clients include law firms, research firms, hedge funds, and certain other entities. He advises law enforcement agencies and professionals about white-collar crime and trains them to catch the crooks.
His views on white-collar crime are frequently quoted in the print news media, online news media, TV media, professional journals, books, and blogs. He has appeared on Fox News, Fox Business Channel, WSJ Live, CNBC, Canadian Broadcasting Corporation, Canadian Business News Network, National Public Radio’s Planet Money, Progressive Radio Network, Reuters TV, RT News, and other media outlets to give insights on white-collar crime. His articles have been published by Business Insider, CNBC, Newsweek, Seeking Alpha, TalkMarkets, and other publications.
Jeff is the President of NewArc Investments Inc., manager of both individual and institutional investments. Jeff is a registered investment advisor, and portfolio manager for NewArc's investment programs.
Jeff is a former college professor with a hands-on, real world attitude. His quantitative modeling helped inform state and local officials in Wisconsin for more than a decade. A Public Policy analyst, he taught advanced research methods at the University of Wisconsin, and analyzed many issues related to state tax policy.
Jeff began in the financial business as Research Director for trading firm at the Chicago Board Options Exchange. He investigated anomalies in the standard option pricing models, taught classes for beginning options traders, and developed new forecasting techniques. In 1991 he established a general research consultancy, working with professional traders at all of the Chicago financial exchanges. In 1998 he started NewArc Investments, Inc.
Jeff has a commitment to the specific needs of individual investors. It is not a one-size-fits all approach, but one that emphasizes the unique circumstances of each client.
Jeff also serves on the board of two small technology companies (currently Chairman at one). He is occasionally as an expert witness in legal cases involving financial markets and hedging.